hotspot -WSS

hotspot

author：entertainment 2025-09-03 07:46:17 - browse：4596

Japanese drugmaker Eisai said Tuesday that Ivan Cheung, chairman of its U.S. operations and global head of its Alzheimer’s disease unit, will retire at the end of the month. The surprise announcement comes just days after Eisai won final approval in the U.S. for its Alzheimer’s drug Leqembi.

Cheung will be replaced in his capacity as head of the Alzheimer’s unit by his brother-in-law Keisuke Naito, 34, who is currently chief ecosystem officer and chief strategy officer. He is also the son of Eisai CEO Haruo Naito.

Tatsuyuki Yasuno, current chief financial officer, will replace Cheung as head of Eisai’s U.S. unit.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： UCB departs biotech trade group BIO

hotspot

WSS

The FDA must approve intranasal treatments for anaphylaxis

STAT Summit: Biotech founders on deal

STAT Summit: Biotech founders on deal

The explosion of genetic testing requires a new approach

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

First Opinion Podcast: Long Covid needs a new approach

explore

hotspot

explore

Hollywood unions extend contract negotiations for actors

STAT Summit: GSK CEO on pharma giant's new direction

Apple is now the first public company to be valued at $3 trillion

Researchers explore possible ties between long Covid, menopause

Malaria cases in Florida and Texas: Here’s what you need to know

Why psychiatrists like me stop taking insurance

Drug repurposing or repositioning? The language matters

STAT Readout Newsletter: Today's biggest biotech updates

Moonlake's readout produced a cash windfall. Risks remain

HHS leader on health, climate change and biopharma emissions

entertainment

Senate committee scrutinizes Medicare Advantage brokers

The EU Joint Clinical Assessment needs to live up to its promise

Beam Therapeutics to lay off 20% of its staff, re

Impact of Dobbs ruling felt at reproductive medicine meeting

Antibiotic resistance and the global rise in human conflict

UnitedHealth’s board chair also owns a personal investment firm

explore

entertainment

hotspot

leisure time